Results 1 to 10 of about 252,929 (281)

Anger and substance abuse: a systematic review and meta-analysis [PDF]

Brazilian Journal of Psychiatry, 2021
Objective: Conduct a systematic review and meta-analysis to evaluate levels of anger among substance users compared to non-user controls and to analyze the possible association between anger and psychoactive substance use (PSU).
Helen V. Laitano, Amanda Ely, Anne O. Sordi, Felipe B. Schuch, Flavio Pechansky, Thiago Hartmann, Juliana B. Hilgert, Eliana M. Wendland, Lisia Von Dimen, Juliana N. Scherer, Alessandra Mendes Calixto, Joana C.M. Narvaez, Felipe Ornell, Félix H.P. Kessler   +13 more
doaj   +2 more sources

Resources for the Assessment and Treatment of Substance Use Disorder in Adolescents

WikiJournal of Medicine, 2023
Substance Use Disorder (SUD) is understood as the persistent use of substances to the detriment of the individual's livelihood and wellness. SUD can have serious mental, physical, and social ramifications if not properly addressed. Though SUD can develop
Emily Pender, Liana Kostak, Kelsey Sutton, Cody Naccarato, Angelina TsaI, Tammy Chung, Stacey Daughters   +6 more
doaj   +1 more source

Alienation and Lack of Trust

Journal of Extreme Anthropology, 2020
Anabolic-androgenic steroid (AAS) use became illegal when the Norwegian Drug Act was amended in 2013, and AAS and other image- and performance-enhancing drugs were included in the politics and treatment of substance use.
Ingrid Amalia Havnes, Thea Steen Skogheim   +1 more
doaj   +1 more source

Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires

Substance Abuse Treatment, Prevention, and Policy, 2019
Background Anabolic-androgenic steroids (AAS) are used to increase muscle strength and improve appearance, but users also carry the risk of developing physical and mental health problems.
Ingrid Amalia Havnes, Marie Lindvik Jørstad, Christine Wisløff   +2 more
doaj   +1 more source

The Anabolic Androgenic Steroid Treatment Gap: A National Study of Substance Use Disorder Treatment

Substance Abuse: Research and Treatment, 2020
Background: Anabolic androgenic steroid (AAS) use is associated with serious mental and physical health problems. Evidence indicates that AAS use among people who use psychoactive substances is higher than in the general population.
Ingrid Amalia Havnes, Marie Lindvik Jørstad, Jim McVeigh, Marie-Claire Van Hout, Astrid Bjørnebekk   +4 more
doaj   +1 more source

Discharge from the trauma centre: exposure to opioids, unmet information needs and lack of follow up—a qualitative study among physical trauma survivors

Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 2021
Background Physical trauma is associated with mortality, long-term pain and morbidity. Effective pain management is fundamental in trauma care and opioids are indispensable for treating acute pain; however, the use and misuse of prescribed opioids is an ...
Jeanette Finstad, Olav Røise, Leiv Arne Rosseland, Thomas Clausen, Ingrid Amalia Havnes   +4 more
doaj   +1 more source

Strengthening partnerships between substance use researchers and policy makers to take advantage of a window of opportunity

Substance Abuse Treatment, Prevention, and Policy, 2019
Background The National Institute on Drug Abuse has identified a persistent research-to-practice gap in the implementation of evidence-based prevention and treatment programs for substance use disorder. To identify mechanisms to close this gap, we sought
Zachary F. Meisel, Julia Mitchell, Daniel Polsky, Nada Boualam, Ellen McGeoch, Janet Weiner, Matthew Miclette, Jonathan Purtle, Bruce Schackman, Carolyn C. Cannuscio   +9 more
doaj   +1 more source

Substance use and substance use disorder, in relation to COVID-19: protocol for a scoping review

Systematic Reviews, 2021
Background The COVID-19 pandemic is creating severe issues for healthcare and broad social structures, exposing societal vulnerabilities. Among the populations affected by COVID-19 are people engaged in substance use, such as people who smoke; vape (e ...
Navin Kumar, Kamila Janmohamed, Kate Nyhan, Silvia S. Martins, Magdalena Cerda, Deborah Hasin, Jenny Scott, Richard Pates, Lilian Ghandour, Mayyada Wazaify, Kaveh Khoshnood   +10 more
doaj   +1 more source

Altered expression of somatostatin signaling molecules and clock genes in the hippocampus of subjects with substance use disorder

Frontiers in Neuroscience, 2022
Substance use disorders are a debilitating group of psychiatric disorders with a high degree of comorbidity with major depressive disorder. Sleep and circadian rhythm disturbances are commonly reported in people with substance use disorder and major ...
Jake Valeri, Jake Valeri, Sinead M. O’Donovan, Wei Wang, David Sinclair, Ratna Bollavarapu, Barbara Gisabella, Barbara Gisabella, Donna Platt, Donna Platt, Craig Stockmeier, Craig Stockmeier, Harry Pantazopoulos, Harry Pantazopoulos   +13 more
doaj   +1 more source

Predicting Dropout from Inpatient Substance Use Disorder Treatment: A Prospective Validation Study of the OQ-Analyst

Substance Abuse: Research and Treatment, 2019
Background and Aims: There is an urgent need for tools allowing therapists to identify patients at risk of dropout. The OQ-Analyst, an increasingly popular computer-based system, is used to track patient progress and predict dropout.
Hanne H Brorson, Espen Ajo Arnevik, Kim Rand   +2 more
doaj   +1 more source